Skip to main content
Clinical Trials/IRCT20200122046221N2
IRCT20200122046221N2
Recruiting
Phase 3

Ovulation induction with clomiphene citrate and letrozole vesus letrozole and cabergoline in fertility rate and its complications in infertile polycystic ovary syndrome women referred to gynecologic clinic

Jahrom University of Medical Sciences0 sites60 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Jahrom University of Medical Sciences
Enrollment
60
Status
Recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Jahrom University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Infertile women with polycystic ovary syndrome who have not had a history of pregnancy without contraception after 12 months
  • Women with no ovulation
  • Normal hysterosalpingography with open fallopian tubes
  • Diagnosis of infertility by non\-ovulation, which is diagnosed according to standard criteria
  • Written conscious desire and satisfaction
  • Infertility at the age of 15\-45 years

Exclusion Criteria

  • Uterine and adnexal pathology such as leiomyoma, endometriosis, etc.
  • Hyperprolactinemia/Hyperthyroidism or hypothyroidism
  • Liver or kidney dysfunction
  • Diabetes mellitus or random blood sugar above 140 mg / dL
  • Previous genital surgery
  • Appendicitis, peritonitis, genital tuberculosis in history or having abnormal pelvic anatomy
  • FSH above 9 in the early stage of the follicular phase

Outcomes

Primary Outcomes

Not specified

Similar Trials